Haloarene Derivatives of Carbamazepine with Reduced Bioactivation Liabilities: 2‑Monohalo and 2,8-Dihalo Derivatives

The anticonvulsant carbamazepine 1 is associated with adverse drug reactions (ADRs), including hepatotoxicity; oxidative metabolism of 1 has been implicated in the pathogenesis of the ADRs. We report the synthesis and evaluation of 2-monohalo and 2,8-dihalo analogues of 1 that were intended to minim...

Full description

Saved in:
Bibliographic Details
Published inJournal of medicinal chemistry Vol. 55; no. 22; pp. 9773 - 9784
Main Authors Elliott, Emma-Claire, Regan, Sophie L, Maggs, James L, Bowkett, Elizabeth R, Parry, Laura J, Williams, Dominic P, Park, B. Kevin, Stachulski, Andrew V
Format Journal Article
LanguageEnglish
Published WASHINGTON American Chemical Society 26.11.2012
Amer Chemical Soc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The anticonvulsant carbamazepine 1 is associated with adverse drug reactions (ADRs), including hepatotoxicity; oxidative metabolism of 1 has been implicated in the pathogenesis of the ADRs. We report the synthesis and evaluation of 2-monohalo and 2,8-dihalo analogues of 1 that were intended to minimize reactive metabolite formation via arene oxidation and 10,11-epoxidation. Halo analogues were obtained either by rearrangement of halogenated N-arylindoles or from specifically halogenated iminodibenzyl derivatives. In rat hepatocytes, none of the analogues underwent oxidative dehalogenation or glutathione adduction. Some formation of the 10,11-epoxide still occurred, but aromatic hydroxylation was not seen with the exception of 2-fluoro, which allowed minor monohydroxylation. Complete inhibition of aromatic hydroxylation required at least monochlorination or difluorination of 1. In human liver microsomes, difluoro analogue 5b underwent 10,11-epoxidation but gave no arene oxidation.
Bibliography:researchfish
UKRI
ISSN:0022-2623
1520-4804
DOI:10.1021/jm301013n